Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anthranylalkyl and cycloalkyl amides and use thereof as VEGF receptor inhibitors

Anthranylalkyl and cycloalkyl amides and use thereof as VEGF receptor inhibitors

US Patent 6818661 · Granted Nov 16, 2004

Estimated economic value: $19,212,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-αβTCR antibody2021
Methods for enhancing immunosuppressive therapy by multiple administration of αβ2021
Anti-αβTCR antibody2018
Compounds for binding to the platelet specific glycoprotein IIb/IIIa and their u2017
BET protein-inhibiting 5-aryltriazoleazepines2017
Compounds for binding to the platelet specific glycoprotein IIB/IIIA and their u2016
Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molec2016
Radiolabeled amino acids for diagnostic imaging2016
Binder-drug conjugates (ADCs) and use thereof2015
Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferat2014
Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molec2014
Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising sam2014